News
expires March 2021 • Irbesartan HCTZ, 150 mg/12.5mg 30 count, lot number 325D18004, expires March 2021 • Irbesartan HCTZ, 150 mg/12.5 mg, 90 count, lot number 325B18004, expires March ...
All batches of Irbesartan tablets in 75 mg, 150 mg and 300 mg strengths and Irbesartan and Hydrochlorothiazide tablets in 150 mg/12.5 mg and 300 mg/12.5 mg strengths made by Lupin Pharmaceuticals ...
It's recalling: All batches of irbesartan tablets USP 75mg, 150mg and 300mg All batches of irbesartan and hydrochlorothiazide tablets USP, 150mg/12.5mg and 300mg/12.5mg Lupin says it received four ...
Irbesartan (Sebri 150 mg) is an angiotensin II receptor blocker (ARB), prescribed for high blood pressure either alone or combined with other medications. It is also used to treat kidney disorders ...
and patients who provided consent were randomly assigned to receive irbesartan once daily (at a dose of 150 mg per day for 2 weeks, and 300 mg per day thereafter) or placebo. Assignment was ...
327B18008 and 327B18009, expiration 03/2021. Irbesartan HCTZ 150mg/12.5mg, 30-count, lot Nos. 325D18004 and 325D18005, expiration 03/2021. Irbesartan HCTZ 150mg/12.5mg, 90-count ...
"Although Lupin has received no reports of illness that appear to relate to this issue, the company, out of an abundance of caution, is recalling all batches of Irbesartan Tablets USP 75mg, 150mg ...
Out of an abundance of caution, Lupin is recalling all batches of Irbesartan Tablets USP 75mg, 150mg and 300mg and Irbesartan and Hydrochlorothiazide Tablets USP, 150mg/12.5mg and 300mg/12.5mg in ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results